[10-Q] Envirotech Vehicles, Inc. Quarterly Earnings Report
Envirotech Vehicles, Inc. reported interim results reflecting a business pivot into medical supplies and drones and a 1-for-10 reverse stock split that retroactively adjusted per-share data. For the three months ended June 30, 2025, the company recognized net revenue of ($25,237) from electric vehicle deliveries after customer credits and $1,072,266 from medical supplies (one related party accounted for 100% of medical supplies revenue). The company recorded out-of-period adjustments totaling $526,535 to correct prior-period sales and R&D expense. Trade receivables totaled $846,982 with an allowance of $406,690. Finished goods inventory netted $4,855,679 after a $1,184,731 valuation allowance. The company has convertible promissory notes, recent conversions into common stock, and access to an investor purchase agreement of up to $25 million.
Envirotech Vehicles, Inc. ha comunicato risultati provvisori che riflettono un cambio di attività verso forniture mediche e droni e un raggruppamento azionario 1-per-10 che ha adeguato retroattivamente i dati per azione. Per i tre mesi conclusi al 30 giugno 2025, la società ha rilevato ricavi netti di ($25.237) dalle consegne di veicoli elettrici dopo accrediti ai clienti e $1.072.266 dalle forniture mediche (una parte correlata ha rappresentato il 100% dei ricavi da forniture mediche). La società ha registrato rettifiche fuori periodo per un totale di $526.535 per correggere vendite e costi di R&S dei periodi precedenti. I crediti commerciali ammontavano a $846.982 con un fondo svalutazione di $406.690. Le rimanenze di prodotti finiti risultano nette per $4.855.679 dopo una svalutazione di $1.184.731. La società detiene cambiali convertibili, conversioni recenti in azioni ordinarie e accesso a un accordo di sottoscrizione con investitori fino a $25 milioni.
Envirotech Vehicles, Inc. informó resultados interinos que reflejan un giro del negocio hacia suministros médicos y drones y una consolidación de acciones 1 por 10 que ajustó retroactivamente los datos por acción. Para los tres meses terminados el 30 de junio de 2025, la compañía reconoció ingresos netos de ($25.237) por entregas de vehículos eléctricos después de créditos a clientes y $1.072.266 por suministros médicos (una parte relacionada representó el 100% de los ingresos por suministros médicos). La compañía registró ajustes fuera de período por un total de $526.535 para corregir ventas y gastos de I+D de periodos anteriores. Las cuentas por cobrar comerciales totalizaron $846.982 con una provisión de $406.690. El inventario de productos terminados quedó neto en $4.855.679 después de una provisión por valoración de $1.184.731. La compañía tiene pagarés convertibles, conversiones recientes a acciones comunes y acceso a un acuerdo de compra de inversores por hasta $25 millones.
Envirotech Vehicles, Inc.는 의료용품과 드론으로 사업을 전환한 중간 실적과 주식 액면 병합(1주를 10주로 병합하는 역분할)이 주당 수치를 소급 조정한 내용을 보고했습니다. 2025년 6월 30일로 끝나는 3개월 동안 회사는 고객 크레딧 반영 후 전기차 인도에서 ($25,237)의 순매출을, 의료용품에서 $1,072,266의 매출을 인식했습니다(의료용품 매출의 100%는 관련 당사자 하나에서 발생). 회사는 전기 매출 및 연구개발비를 정정하기 위해 총 $526,535의 기간 외 조정을 기록했습니다. 매출채권은 $846,982였고 대손충당금은 $406,690이었습니다. 완제품 재고는 $1,184,731의 평가충당금을 반영한 순액 $4,855,679였습니다. 회사는 전환사채, 최근 보통주 전환, 최대 $2,500만 달러의 투자자 매입계약 접근권을 보유하고 있습니다.
Envirotech Vehicles, Inc. a communiqué des résultats intérimaires reflétant une réorientation vers les fournitures médicales et les drones ainsi qu'un regroupement d'actions 1 pour 10 qui a ajusté rétroactivement les données par action. Pour les trois mois clos le 30 juin 2025, la société a constaté un chiffre d'affaires net de ($25 237) lié aux livraisons de véhicules électriques après crédits clients et de $1 072 266 provenant des fournitures médicales (une partie liée représentait 100 % des revenus de fournitures médicales). La société a enregistré des ajustements hors période totalisant $526 535 pour corriger des ventes et des charges R&D antérieures. Les créances commerciales s'élevaient à $846 982 avec une provision de $406 690. Les stocks de produits finis s'établissent nets à $4 855 679 après une provision pour dépréciation de $1 184 731. La société détient des billets à ordre convertibles, des conversions récentes en actions ordinaires et l'accès à un accord d'achat par des investisseurs allant jusqu'à $25 millions.
Envirotech Vehicles, Inc. meldete vorläufige Ergebnisse, die eine Geschäftsausrichtung auf medizinische Versorgung und Drohnen sowie eine 1-zu-10-Aktienzusammenlegung widerspiegeln, welche die Gewinn-/Verlustangaben je Aktie rückwirkend angepasst hat. Für die drei Monate zum 30. Juni 2025 erzielte das Unternehmen einen Nettoumsatz von ($25.237) aus Lieferungen von Elektrofahrzeugen nach Kundenkrediten und $1.072.266 aus medizinischen Lieferungen (ein verbundenes Unternehmen machte 100 % des Umsatzes aus medizinischen Lieferungen aus). Das Unternehmen nahm periodenfremde Korrekturen in Höhe von insgesamt $526.535 vor, um frühere Verkaufs- und F&E-Aufwendungen zu berichtigen. Die Forderungen aus Lieferungen und Leistungen beliefen sich auf $846.982 mit einer Wertberichtigung von $406.690. Die Fertigwarenbestände ergaben nach einer Wertberichtigung von $1.184.731 einen Nettobetrag von $4.855.679. Das Unternehmen verfügt über wandelbare Schuldscheine, jüngste Umwandlungen in Stammaktien und Zugang zu einer Investoren-Kaufvereinbarung von bis zu $25 Millionen.
- The company expanded operations by adding medical supplies and drones, creating a new revenue stream that generated $1,072,266 in the quarter.
- The company secured an investor arrangement that provides the right to purchase up to $25 million of common stock, offering potential capital access.
- Revenue concentration: one related-party customer accounted for 100% of medical supplies net revenue for the quarter, and a few customers represented ~93% of electric vehicle receivables.
- Significant allowances: $406,690 allowance for doubtful accounts and a $1,184,731 inventory valuation allowance indicate collectability and inventory risk.
- Net revenue loss in EV segment: electric vehicle deliveries resulted in net revenue of ($25,237) due to customer credits.
- Active convertible promissory notes and recent conversions create potential equity dilution and altered capital structure following conversions and the reverse stock split.
Insights
TL;DR: Concentrated revenues, significant receivable and inventory allowances, and convertible financing materially affect liquidity and equity structure.
The filing shows concentrated revenue streams with one related party providing all medical supplies revenue and a small number of customers representing the bulk of electric vehicle receivables. Large allowances for doubtful accounts and inventory valuation indicate collectability and obsolescence risk. The company has active convertible promissory notes and a $25 million investor purchase agreement that dilutes equity when drawn. The 1-for-10 reverse stock split and multiple conversions changed share counts and additional paid-in capital classifications, which materially affect per-share metrics and capital structure.
TL;DR: Operational adjustments and financing activity are material to short-term cash flow and capital availability.
Out-of-period adjustments of $126,535 (revenue) and $400,000 (R&D) were recorded but deemed immaterial by management; nevertheless, they reflect control and recognition issues. Inventory deposits concentrated with three vendors and significant inventory valuation allowance reduce usable working capital. Several short-term loans and convertible note conversions occurred, including partial conversion of a promissory note and issuance of shares under financing arrangements, impacting liquidity and potential future dilution.
Envirotech Vehicles, Inc. ha comunicato risultati provvisori che riflettono un cambio di attività verso forniture mediche e droni e un raggruppamento azionario 1-per-10 che ha adeguato retroattivamente i dati per azione. Per i tre mesi conclusi al 30 giugno 2025, la società ha rilevato ricavi netti di ($25.237) dalle consegne di veicoli elettrici dopo accrediti ai clienti e $1.072.266 dalle forniture mediche (una parte correlata ha rappresentato il 100% dei ricavi da forniture mediche). La società ha registrato rettifiche fuori periodo per un totale di $526.535 per correggere vendite e costi di R&S dei periodi precedenti. I crediti commerciali ammontavano a $846.982 con un fondo svalutazione di $406.690. Le rimanenze di prodotti finiti risultano nette per $4.855.679 dopo una svalutazione di $1.184.731. La società detiene cambiali convertibili, conversioni recenti in azioni ordinarie e accesso a un accordo di sottoscrizione con investitori fino a $25 milioni.
Envirotech Vehicles, Inc. informó resultados interinos que reflejan un giro del negocio hacia suministros médicos y drones y una consolidación de acciones 1 por 10 que ajustó retroactivamente los datos por acción. Para los tres meses terminados el 30 de junio de 2025, la compañía reconoció ingresos netos de ($25.237) por entregas de vehículos eléctricos después de créditos a clientes y $1.072.266 por suministros médicos (una parte relacionada representó el 100% de los ingresos por suministros médicos). La compañía registró ajustes fuera de período por un total de $526.535 para corregir ventas y gastos de I+D de periodos anteriores. Las cuentas por cobrar comerciales totalizaron $846.982 con una provisión de $406.690. El inventario de productos terminados quedó neto en $4.855.679 después de una provisión por valoración de $1.184.731. La compañía tiene pagarés convertibles, conversiones recientes a acciones comunes y acceso a un acuerdo de compra de inversores por hasta $25 millones.
Envirotech Vehicles, Inc.는 의료용품과 드론으로 사업을 전환한 중간 실적과 주식 액면 병합(1주를 10주로 병합하는 역분할)이 주당 수치를 소급 조정한 내용을 보고했습니다. 2025년 6월 30일로 끝나는 3개월 동안 회사는 고객 크레딧 반영 후 전기차 인도에서 ($25,237)의 순매출을, 의료용품에서 $1,072,266의 매출을 인식했습니다(의료용품 매출의 100%는 관련 당사자 하나에서 발생). 회사는 전기 매출 및 연구개발비를 정정하기 위해 총 $526,535의 기간 외 조정을 기록했습니다. 매출채권은 $846,982였고 대손충당금은 $406,690이었습니다. 완제품 재고는 $1,184,731의 평가충당금을 반영한 순액 $4,855,679였습니다. 회사는 전환사채, 최근 보통주 전환, 최대 $2,500만 달러의 투자자 매입계약 접근권을 보유하고 있습니다.
Envirotech Vehicles, Inc. a communiqué des résultats intérimaires reflétant une réorientation vers les fournitures médicales et les drones ainsi qu'un regroupement d'actions 1 pour 10 qui a ajusté rétroactivement les données par action. Pour les trois mois clos le 30 juin 2025, la société a constaté un chiffre d'affaires net de ($25 237) lié aux livraisons de véhicules électriques après crédits clients et de $1 072 266 provenant des fournitures médicales (une partie liée représentait 100 % des revenus de fournitures médicales). La société a enregistré des ajustements hors période totalisant $526 535 pour corriger des ventes et des charges R&D antérieures. Les créances commerciales s'élevaient à $846 982 avec une provision de $406 690. Les stocks de produits finis s'établissent nets à $4 855 679 après une provision pour dépréciation de $1 184 731. La société détient des billets à ordre convertibles, des conversions récentes en actions ordinaires et l'accès à un accord d'achat par des investisseurs allant jusqu'à $25 millions.
Envirotech Vehicles, Inc. meldete vorläufige Ergebnisse, die eine Geschäftsausrichtung auf medizinische Versorgung und Drohnen sowie eine 1-zu-10-Aktienzusammenlegung widerspiegeln, welche die Gewinn-/Verlustangaben je Aktie rückwirkend angepasst hat. Für die drei Monate zum 30. Juni 2025 erzielte das Unternehmen einen Nettoumsatz von ($25.237) aus Lieferungen von Elektrofahrzeugen nach Kundenkrediten und $1.072.266 aus medizinischen Lieferungen (ein verbundenes Unternehmen machte 100 % des Umsatzes aus medizinischen Lieferungen aus). Das Unternehmen nahm periodenfremde Korrekturen in Höhe von insgesamt $526.535 vor, um frühere Verkaufs- und F&E-Aufwendungen zu berichtigen. Die Forderungen aus Lieferungen und Leistungen beliefen sich auf $846.982 mit einer Wertberichtigung von $406.690. Die Fertigwarenbestände ergaben nach einer Wertberichtigung von $1.184.731 einen Nettobetrag von $4.855.679. Das Unternehmen verfügt über wandelbare Schuldscheine, jüngste Umwandlungen in Stammaktien und Zugang zu einer Investoren-Kaufvereinbarung von bis zu $25 Millionen.
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
| | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED
or
| | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number:
ENVIROTECH VEHICLES, INC.
(Exact name of registrant as specified in its charter)
| | |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification No.) |
| |
| |
| (Address of principal executive offices, including zip code) |
| ( |
| (Registrant’s telephone number, including area code) |
| N/A |
| (Former name, former address and former fiscal year, if changed since last report) |
| Securities registered pursuant to Section 12(b) of the Act: |
|
| Trading | Name of each exchange | ||
| Title of each class | Symbol(s) | on which registered | ||
| | | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| | ☒ | Smaller reporting company | |
| Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of shares outstanding of the registrant’s common stock, $0.00001 par value per share, as of August 12, 2025 was
ENVIROTECH VEHICLES, INC. AND SUBSIDIARIES
TABLE OF CONTENTS
FORM 10-Q FOR THE QUARTERLY PERIOD ENDED June 30, 2025
|
|
PAGE |
|
| Special Note Regarding Forward-Looking Statements | 1 | |
| Part I. FINANCIAL INFORMATION | ||
| Item 1. Financial Statements: |
2 |
|
| Unaudited Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024 |
2 |
|
| Unaudited Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024 |
3 |
|
| Unaudited Consolidated Statement of Stockholders’ Equity for the Three and Six Months Ended June 30, 2025 and 2024 |
4 |
|
| Unaudited Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 |
5 |
|
| Notes to Unaudited Consolidated Financial Statements |
6 |
|
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
16 |
|
| Item 3. Quantitative and Qualitative Disclosure about Market Risk |
21 |
|
| Item 4. Controls and Procedures |
21 |
|
| Part II. OTHER INFORMATION |
||
| Item 1. Legal Proceedings |
22 |
|
| Item 1A. Risk Factors |
22 |
|
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
22 |
|
| Item 3. Defaults Upon Senior Securities |
22 |
|
| Item 4. Mine Safety Disclosures |
22 |
|
| Item 5. Other Information |
22 |
|
| Item 6. Exhibits |
23 |
|
| Signatures |
24 |
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or our future financial performance or condition and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “contemplate,” “plan,” “project,” “forecast,” “potential,” “possible,” “proposed,” “should,” “develop,” “opportunity,” “target,” “outlook,” “optimistic,” “poised,” “positioned,” “maintain,” “continue,” “aim,” “goal,” “will” and “would” or the negatives of these terms or other comparable terminology intended to identify statements about the future.
You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Quarterly Report, including in “Risk Factors” and elsewhere, identify important factors, which you should consider in evaluating our forward-looking statements. These factors could cause actual results and events to differ materially from those expressed or implied in any forward-looking statement and include, among other things:
| • |
our ability to generate demand for our zero-emission commercial fleet vehicles in order to generate revenue; |
| • |
our dependence upon external sources for the financing of our operations; |
| • |
our ability to effectively execute our business plan; |
|
| • | our ability to successfully integrate and realize the benefits of strategic acquisitions; |
| • |
our ability and our suppliers’ ability to scale our zero-emission products assembling processes effectively and quickly from low volume production to high volume production; |
| • |
our ability to manage our expansion, growth and operating expenses and reduce and adequately control the costs and expenses associated with operating our business; |
|
| • | the potential impact of product recalls and product liability claims relating to the products we distribute and other litigation; |
| • |
our ability and our manufacturing partners’ ability to navigate current and future disruptions to the global supply chain and to procure the raw materials, parts, and components necessary to produce our vehicles on terms acceptable to us and our customers; |
| • |
our ability to obtain, retain and grow our customers, and our dependence on a limited number of customers; |
| • |
our ability to enter into, sustain and renew strategic relationships on favorable terms; |
|
| • | our dependence on, and retention of, key personnel; |
| • |
our ability to achieve and sustain profitability; |
|
| • | the impact of legislation and/or government regulation on our business and industry, including, without limitation, the status of government subsidies, rebates and economic incentives that support the development and demand for our products and services; | |
| • | ongoing and anticipated changes in the U.S. political environment, including those resulting from the new Presidential administration, and changes to regulatory agencies; | |
| • | changes in trade policies and the imposition of tariffs and other trade barriers in the jurisdictions where we source our materials or sell our products; |
| • |
our ability to evaluate and measure our current business and future prospects; |
| • |
our ability to compete and succeed in a highly competitive and evolving industry; |
| • |
our ability to respond and adapt to changes in electric vehicle technology; |
|
| • | the cost and adequacy of insurance coverage and increases in the number of severity of insurance and claims expenses; |
| • |
our ability to protect our intellectual property and to develop, maintain and enhance a strong brand; |
|
| • | disruptions in our information technology systems, including, but not limited to, system failures, cyber-attacks, unauthorized physical or electronic access, or other natural or mad-made incidents or disasters; and | |
| • | our ability to maintain compliance with the listing requirements of the Nasdaq Stock Market LLC (“Nasdaq”) and the impact of any steps taken to maintain such compliance, including the Reverse Stock Split (as defined below) on our operations, stock price and future access to funds. |
You should read this Quarterly Report and the documents that we reference elsewhere in this Quarterly Report completely and with the understanding that our actual results may differ materially from what we expect as expressed or implied by our forward-looking statements. Forward-looking statements are subject to a number of known and unknown risks, uncertainties, assumptions and other important factors, including, but not limited to, those discussed in Part I, Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) and in Part II, Item 1A (Risk Factors) of this Quarterly Report as we as in Part I, Item 1 (Business) and Item 1A (Risk Factors and Part II, Item 7 (Management's Discussion and Analysis of Financial Condition and Results of Operations) of our Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on April 15, 2025. In light of the significant risks and uncertainties to which our forward-looking statements are subject, you should not place undue reliance on such forward-looking statements or regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. These forward-looking statements represent our estimates and assumptions only as of the date of this Quarterly Report regardless of the time of delivery of this Quarterly Report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this Quarterly Report.
Unless expressly indicated or the context requires otherwise, references in this Quarterly Report to “Envirotech,” the “Company,” “we,” “our,” and “us” refer to Envirotech Vehicles, Inc., a Delaware corporation, and our consolidated subsidiaries, unless the context indicates otherwise.
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
ENVIROTECH VEHICLES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(unaudited)
| June 30, | December 31, | |||||||
| 2025 | 2024 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Accounts receivable, net of allowance of $406,690 and $15,306 respectively | ||||||||
| Receivable from related party, net of allowance of $40,633 and $6,700 respectively | ||||||||
| Inventory, net | ||||||||
| Inventory deposits | ||||||||
| Prepaid expenses | ||||||||
| Other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Right-of-use asset | ||||||||
| Goodwill | ||||||||
| Intangible assets, net | ||||||||
| Other non-current assets | ||||||||
| Total assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Deferred revenue | ||||||||
| Accrued liabilities | ||||||||
| Operating lease liability - short-term | ||||||||
| Options liability, at fair value | ||||||||
| Debt - current | ||||||||
| Total current liabilities | ||||||||
| Long-term liabilities | ||||||||
| Operating lease liability - long-term | ||||||||
| Debt - long-term | ||||||||
| Total liabilities | ||||||||
| Stockholders’ equity: | ||||||||
| Preferred stock, 5,000,000 authorized, $0.00001 par value per share, none issued and outstanding as of June 30, 2025, and December 31, 2024 | ||||||||
| Common stock, 350,000,000 authorized, $0.00001 par value per share, 3,220,058 and 1,987,262 issued and outstanding as of June 30, 2025, and December 31, 2024, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | $ | $ | ||||||
See Accompanying Notes to Unaudited Consolidated Financial Statements.
ENVIROTECH VEHICLES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| June 30, | June 30, | June 30, | June 30, | |||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Sales, net | $ | $ | $ | $ | ||||||||||||
| Cost of sales | ||||||||||||||||
| Gross profit | ( | ) | ( | ) | ||||||||||||
| Operating expenses | ||||||||||||||||
| General and administrative | ||||||||||||||||
| Consulting | ||||||||||||||||
| Research and development | ||||||||||||||||
| Goodwill impairment | ||||||||||||||||
| Total operating expenses, net | ||||||||||||||||
| Loss from operations | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Other (expense)/income: | ||||||||||||||||
| Interest income (expense), net | ( | ) | ( | ) | ||||||||||||
| Unrealized loss on financial instruments at fair value | ( | ) | ( | ) | ( | ) | ||||||||||
| Realized loss on conversion of convertible notes | ( | ) | ( | ) | ||||||||||||
| Other income/(expense) | ( | ) | ( | ) | ||||||||||||
| Total other expense | ( | ) | ( | ) | ( | ) | ||||||||||
| Loss before income taxes | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
| Income tax expense | ||||||||||||||||
| Net loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Net loss per share to common stockholders: | ||||||||||||||||
| Basic and diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Weighted average shares used in the computation of net loss per share: | ||||||||||||||||
| Basic and diluted | ||||||||||||||||
See Accompanying Notes to Unaudited Consolidated Financial Statements.
ENVIROTECH VEHICLES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
Three and Six Months Ended June 30, 2025 and 2024
(unaudited)
| Additional | ||||||||||||||||||||
| Common Stock | Paid-In | Accumulated | Stockholders’ | |||||||||||||||||
| Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||
| Balance, December 31, 2024 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Convertible note conversion | ||||||||||||||||||||
| Stock based compensation | — | |||||||||||||||||||
| Net loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance, March 31, 2025 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Common stock issued from convertible notes conversion | ||||||||||||||||||||
| Stock based compensation | — | |||||||||||||||||||
| Net loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance, June 30, 2025 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Additional | ||||||||||||||||||||
| Common Stock | Paid-In | Accumulated | Stockholders’ | |||||||||||||||||
| Shares | Amount | Capital | Deficit | Equity | ||||||||||||||||
| Balance, December 31, 2023 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Common stock issued for cash | ||||||||||||||||||||
| Stock based compensation | — | |||||||||||||||||||
| Net loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance, March 31, 2024 | $ | $ | $ | ( | ) | $ | ||||||||||||||
| Common stock issued for cash | ||||||||||||||||||||
| Stock based compensation | — | |||||||||||||||||||
| Net loss | — | ( | ) | ( | ) | |||||||||||||||
| Balance, June 30, 2024 | $ | $ | $ | ( | ) | $ | ||||||||||||||
See Accompanying Notes to Unaudited Consolidated Financial Statements.
ENVIROTECH VEHICLES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
| Six Months Ended | ||||||||
| June 30, | ||||||||
| 2025 | 2024 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization | ||||||||
| Unrealized loss on financial instruments at fair value | ||||||||
| Realized loss on conversion of convertible notes | ||||||||
| Goodwill impairment charge | ||||||||
| Stock based compensation expense | ||||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | ( | ) | ||||||
| Receivable from related party | ( | ) | ||||||
| Inventory | ||||||||
| Inventory deposits | ( | ) | ||||||
| Prepaid expenses | ||||||||
| Other current assets | ||||||||
| Other non-current assets | ( | ) | ||||||
| Accounts payable | ||||||||
| Accrued liabilities | ( | ) | ||||||
| Deferred revenue | ||||||||
| Other liabilities | ( | ) | ||||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from investing activities: | ||||||||
| Purchase of property and equipment | ( | ) | ( | ) | ||||
| Net cash used in investing activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities: | ||||||||
| Proceeds from issuance of common stock | ||||||||
| Proceeds from issuance of convertible note | ||||||||
| Proceeds from debt | ||||||||
| Principal repayments on debt | ( | ) | ( | ) | ||||
| Net cash provided by financing activities | ||||||||
| Net change in cash, restricted cash and cash equivalents | ( | ) | ( | ) | ||||
| Cash and cash equivalents at the beginning of the period | ||||||||
| Cash and cash equivalents at the end of the period | $ | $ | ||||||
| Supplemental cash flow disclosures: | ||||||||
| Cash paid for interest expense | $ | $ | ||||||
| Non-cash transfer of inventory deposits to property and equipment | $ | $ | ||||||
| Cancellation of Convertible note cancelled and transferred to Notes payable - current | $ | $ | ||||||
| Conversion of short-term note to common stock | $ | $ | ||||||
| Capital expenditures unpaid on June 30, 2025 and June 30, 2024 | $ | $ | ||||||
See Accompanying Notes to Unaudited Consolidated Financial Statements.
ENVIROTECH VEHICLES, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
| 1. | Organization and Operations |
Envirotech Vehicles, Inc., including its consolidated subsidiaries (the "Company"), is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies, and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles. The Company’s vehicles address the challenges of traditional fuel price cost instability and local, state, and federal regulatory compliance. During the first quarter of 2025, the Company increased its business portfolio by adding two new business operations: (1) medical supplies and (2) drones.
On August 8, 2025, the Company effected a 1-for-
| 2. | Summary of Significant Accounting Policies |
Basis of Presentation—These unaudited consolidated financial statements are prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") regarding interim financial reporting. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States ("U.S.") generally accepted accounting principles (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. In the Company’s opinion, these unaudited financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These unaudited financial statements should be read in conjunction with the Company's audited financial statements for the years ended December 31, 2024 and 2023 included in the Company’s Annual Report on Form 10-K filed with the SEC on April 15, 2025. The results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results to be expected for the full year.
Out of Period Adjustment—During the three months ended June 20, 2025, the Company recorded out-of-period adjustments to correct errors related to the understatement of the sales and the understatement of research and development expense that were incorrectly omitted from the financial statements for the period ended March 31, 2025. Regarding the adjustment to sales the Company did not record sales for the three-month period ended March 31, 2025 due to lack of evidence that the performance obligation was met. An adjustment of $
Fair Value of Financial Instruments—The carrying values of the Company’s financial instruments, including cash, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these financial instruments. Accounting Standards Codification ("ASC") 820, Fair Value Measurements ("ASC 820") defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
Level 1: Observable inputs such as quoted prices in active markets;
Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
Level 3: Unobservable inputs that are supported by little or no market data and that require the reporting entity to develop its own assumptions.
The Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis other than the options liability and convertible note disclosed in Note 5 - Debt, in which the Company has elected the fair value option.
Revenue Recognition—The Company recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services and delivery of medical supplies to the customers of its related party. The Company recognizes revenue in accordance with Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers ("ASC 606"), which requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company recorded net revenue of ($
Net revenue recorded for the six months ended June 30, 2025 was $
In applying ASC 606, the Company is required to:
| (1) | identify any contracts with customers; |
| (2) | determine if multiple performance obligations exist; |
| (3) | determine the transaction price; |
| (4) | allocate the transaction price to the respective obligation; and |
| (5) | recognize the revenue as the obligation is satisfied. |
Product revenue primarily includes the sale of electric trucks and cargo vans. These sales represent a single performance obligation and revenue is recognized when the vehicle is delivered, the customer has accepted the vehicle and signed the appropriate documentation acknowledging receipt of the vehicle. At this time, the title of the vehicle is transferred to the customer.
Medical supply revenue is recognized at the point in time when control transfers to the customer, which in this arrangement, occurs when the gowns are delivered.
Cash and Cash Equivalents—The Company considers all highly liquid investments purchased with an original or remaining maturity of three months or less to be cash equivalents. The recorded value of our restricted cash and cash equivalents approximates their fair value. The Company had
Accounts Receivable and Allowance for Doubtful Accounts— The accounts receivable balance relates to the Company's electric vehicles segment. The Company establishes an allowance for bad debts through a review of several factors, including historical collection experience, current aging status of the customer accounts, and financial condition of its customers. The Company does not generally require collateral for its accounts receivable. The Company had trade accounts receivable of $
Receivable from Related Party and Allowance for Doubtful Accounts—The receivable from related party relates to the Company's medical supplies segment. The allowance for doubtful accounts is established by reviewing several factors, including historical collection experience, current aging of the customer account and financial condition of its customer. The Company had receivable from related party of $2,195,880 and a recorded allowance of $
Inventory and Inventory Valuation Allowance—The Company records inventory at the lower of cost or market, and uses a First In, First Out accounting valuation methodology and establishes an inventory valuation allowance for vehicles that it does not intend to sell in the future or when their cost has fallen below net realizable value. The Company had finished goods inventory on hand of $
Inventory Deposits—Certain of our vendors require the Company to pay upfront deposits before they commence manufacturing our vehicles and then require progress deposits through the production cycle and before the finished vehicles are shipped. These deposits are classified as inventory deposits in the consolidated balance sheets. Upon completion of production acceptance by the Company, and passage of title to the Company, deposits are reclassified to inventory. The Company had inventory deposits of $
Income Taxes—The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes.
Accounting for Uncertainty in Income Taxes—The Company evaluates its uncertain tax positions and will recognize a loss contingency when it is probable that a liability has been incurred as of the date of the financial statements and the amount of the loss can be reasonably estimated. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount recognized. At June 30, 2025 and December 31, 2024, respectively, management did not identify any uncertain tax positions.
Net Loss Per Share—Basic net loss per share is calculated by dividing the Company’s net loss applicable to common stockholders by the weighted average number of shares of common stock outstanding during the period. For the periods presented, the diluted loss per share and basic loss per share calculations are the same as the diluted loss per share calculation would be anti-dilutive.
Diluted net loss per share is calculated by dividing the Company’s net loss applicable to common stockholders by the diluted weighted average number of shares of common stock outstanding during the period. The diluted weighted average number of shares of common stock outstanding is the basic weighted number of shares of common stock adjusted for any potentially dilutive debt or equity securities. As of June 30, 2025,
Concentration of Credit Risk—The Company has credit risks related to cash and cash equivalents on deposit with a federally insured bank, as at times it exceeds the $250,000 maximum amount insured by the Federal Deposit Insurance Corporation (“FDIC”). Additionally, the Company may maintain cash and short-term securities invested at Arvest Bank, National Association (“Arvest”). Between FDIC and the Securities Investor Protection Corporation (“SIPC”) coverage, funds up to $
Impairment of Long-Lived Assets—Long-lived assets, including property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company evaluates these assets to determine potential impairment by comparing the carrying amount to the undiscounted estimated future cash flows of the related assets. If the estimated undiscounted cash flows are less than the carrying value of the assets, the assets are written down to their fair value. There was
Goodwill—Goodwill represents the excess of acquisition cost over the fair value of the net tangible and intangible assets acquired. Goodwill is not amortized and is subject to annual impairment testing on or between annual tests if an event or change in circumstance occurs that would more likely than not reduce the fair value of a reporting unit below its carrying value. In testing for goodwill impairment, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances lead to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company concludes that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, it can conclude the assessment. If the Company concludes otherwise, the Company is required to perform a quantitative analysis to determine the amount of impairment, if any.
The Company has determined that it has three reporting units, and based on both qualitative and quantitative analysis and based on management’s assessment, the Company recorded a non-cash impairment of $
Research and Development—Costs incurred in connection with the development of new products and manufacturing methods are charged to operating expenses as incurred. Research and development costs were $
Stock-Based Compensation—The Company accounts for employee stock-based compensation in accordance with the guidance of ASC 718, Stock-Based Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered. Non-cash stock-based compensation expense of $
Property and Equipment— Property and equipment are stated at cost, less accumulated depreciation. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets, which range from three to five years, except leasehold improvements, which are being amortized over the life of the lease term. Property and equipment qualify for capitalization if the purchase price exceeds $2,000. Major repairs and replacements, which extend the useful lives of equipment, are capitalized and depreciated over the estimated useful lives of the property. All other maintenance and repairs are expensed as incurred. See Note 3 - Property and Equipment, net.
Other Intangibles— Other intangibles are stated at cost, less accumulated amortization. The Company records amortization expense using the straight-line method over the estimated useful lives of these assets, which range from three to ten years. See Note 4 - Goodwill and Other Intangibles.
Leases—The Company accounts for leases in accordance with ASC 842, Leases (“ASC 842”). At the inception or modification of a contract, the Company determines whether a lease exists and classifies its leases as an operating or finance lease at commencement. Right-of-use ("ROU") assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent their obligation to make lease payments arising from the lease. See Note 12 - Leases.
As most of the Company’s leases do not provide an implicit interest rate, the lease liability is calculated at lease commencement as the present value of unpaid lease payments using the Company’s estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach based on information available at the commencement date of the lease.
The lease asset also reflects any prepaid rent, initial direct costs incurred, and lease incentives received. The Company’s lease terms may include optional extension periods when it is reasonably certain that those options will be exercised.
Leases with an initial expected term of 12 months or less are not recorded in the Company's consolidated balance sheets and the related lease expense is recognized on a straight-line basis over the lease term. For certain classes of underlying assets, the Company has elected to not separate fixed lease components from the fixed non-lease components.
Recently Issued Accounting Pronouncements Not Yet Adopted
ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"), which requires public entities, on an annual basis, to provide disclosure of specific categories in the reconciliation of the effective tax rate, as well as disclosure of income taxes paid, disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09 and will adopt the guidance when it becomes effective on a prospective basis.
ASU No. 2024-03, “Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses”
In November 2024, the FASB issued ASU 2024-03, Income Statement (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03"), which requires additional information about certain expenses in the notes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03 and will adopt the guidance when it becomes effective on a prospective basis.
| 3. | Property and Equipment, Net |
Components of property and equipment, net, consist of the following as of June 30, 2025 and December 31, 2024:
| June 30, | December 31, | |||||||
| 2025 | 2024 | |||||||
| Furniture and fixtures | $ | $ | ||||||
| Leasehold improvements | ||||||||
| Machinery and equipment | ||||||||
| Electric buses | ||||||||
| Vehicles | ||||||||
| Test/Demo vehicles | ||||||||
| Total property and equipment | ||||||||
| Less accumulated depreciation | ( | ) | ( | ) | ||||
| Net property and equipment | $ | $ | ||||||
Depreciation expense was $
| 4. | Goodwill and Other Intangibles |
During the first quarter of 2025, the Company concluded that a triggering event had occurred as a result of a decline of the Company's stock price. Consequently, the Company conducted an impairment test for the first quarter of 2025 and recorded a non-cash impairment of $
The following table presents a reconciliation of the carrying amount of goodwill for the six months ended June 30, 2025.
| Total | ||||
| Goodwill as of December 31, 2023 | $ | |||
| Increase due to acquisitions | ||||
| Goodwill as of December 31, 2024 | ||||
| Goodwill Impairment | ( | ) | ||
| Goodwill as of June 30, 2025 | $ | |||
| As of June 30, 2025 | ||||||||||||||||
| Weighted average amortization period (in years) | ||||||||||||||||
| Gross carrying amount | Accumulated amortization | Net amount | ||||||||||||||
| Intangible assets: | ||||||||||||||||
| Customer relationships | $ | $ | ( | ) | $ | |||||||||||
| Trade names and trademarks | ( | ) | $ | |||||||||||||
| Intangible assets, net | $ | $ | ( | ) | $ | |||||||||||
| As of December 31, 2024 | ||||||||||||||||
| Weighted average amortization period (in years) | ||||||||||||||||
| Gross carrying amount | Accumulated amortization | Net amount | ||||||||||||||
| Intangible assets: | ||||||||||||||||
| Customer relationships | $ | $ | ( | ) | $ | |||||||||||
| Trade names and trademarks | ( | ) | $ | |||||||||||||
| Intangible assets, net | $ | $ | ( | ) | $ | |||||||||||
Amortization expense was $
| Amortization expense | ||||
| Remainder of 2025 | $ | |||
| 2026 | $ | |||
| 2027 | $ | |||
| 2028 | $ | |||
| 2029 and beyond | $ | |||
| 5. | Debt |
Notes Payable
On July 15, 2022, the Company entered into an equipment financing agreement with Wells Fargo Bank, N.A. in connection with the purchase of facility grounds equipment. The $
On June 15, 2024, the Company entered into a premium financing agreement with First Insurance Funding to finance its directors' and officers' insurance coverages. The $
On June 15, 2025, the Company entered into a premium financing agreement with AFCO Insurance Premium Finance to finance its directors' and officers' insurance coverages. The $
On August 20, 2024, the Company entered into a premium financing agreement with AFCO Insurance Premium Finance to finance insurance coverages other than its directors' and officers' insurance coverages. The $
Convertible Note
On January 18, 2024, the Company entered into a convertible promissory note agreement ("Note") for $
The Company has elected to measure the remaining options at fair value. In estimating the fair value of the options, the Black-Scholes Merton Model is used. The required inputs include the current stock price, the exercise price, the term of the options, the risk-free rate and the volatility of the common stock. The options' fair value is classified a Level 3 under the fair value hierarchy as provided by ASC 820. The fair valuation of the options uses inputs other than quoted prices that are observable either directly or indirectly.
The net proceeds of $
The Company recorded an unrealized gain of $
Amended and Restated Standby Equity Purchase Agreement ("A&R SEPA")
On October 31, 2024, the Company entered into A&R SEPA with YA II PN, Ltd. (the "Investor"). The A&R SEPA amends and restates in its entirety the standby equity purchase agreement, dated September 23, 2024, by and between the Company and the Investor (the “Original SEPA”).
Pursuant to the A&R SEPA, except for so long as there is a balance outstanding under the Promissory Notes (as defined below) and the Additional Promissory Notes (as defined below), the Company has the right, from time to time, until November 1, 2027, to require the Investor to purchase up to $
During the first quarter of 2025, the obligation under the EVTV-2 Promissory Note in the principal amount of $
During the same quarter, the obligation under the EVTV-1 Promissory Note was partially satisfied through the conversion of the EVTV-1 Promissory Note into shares of the Company's common stock. As a result of this conversion,
The Company has elected to measure the Promissory Notes at fair value. In estimating the fair value of the Promissory Notes, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of the common stock. The Promissory Notes' fair values are classified as Level 3 under the fair value hierarchy as provided by ASC 820. As a result of this election, the Company recorded an unrealized gain of $
Supplemental Agreement to A&R SEPA
On February 24, 2025, the Company entered into a supplemental agreement, dated February 24, 2025 (the “Supplemental Agreement”), with the Investor, which amends and supplements the A&R SEPA to: (i) provide for the advancement by the Investor to the Company, subject to the satisfaction of certain conditions as set forth in the Supplemental Agreement, of $
The Additional Promissory Notes accrue interest on the outstanding principal balance at an annual rate equal to
The first tranche of the Additional Pre-Paid Advance was disbursed on February 25, 2025 in the principal amount of $
The second tranche of the Additional Pre-Paid Advance in the principal amount of $
The Company has elected to measure the Additional Promissory Notes at fair value. In estimating the fair value of the Additional Promissory Notes, a lattice model is applied. The required inputs include the current stock price, the term, the conversion price, the risk-free rate and volatility of the Company's common stock. The Additional Promissory Notes' fair values are classified as Level 3 under the fair value hierarchy as provided by ASC 820. As a result of this election, the Company recorded an unrealized loss of $
The following table depicts the future annual minimum payments of the Company's outstanding debt as of June 30, 2025:
| Amount | ||||
| Remainder of 2025 | $ | |||
| 2026 | ||||
| Total Payments | $ | |||
| 6. | Stockholders’ Equity |
The Company has
The Company has
A&R SEPA
On September 23, 2024, the Company entered into the Original SEPA, which was amended and restated pursuant to the A&R SEPA on October 31, 2024. Pursuant to the A&R SEPA, except for so long as there is a balance outstanding under the Promissory Notes and the Additional Promissory Notes and subject to certain limitations and conditions set forth therein, the Company has the right, but not the obligation, to sell to the Investor, and the Investor agreed to purchase from the Company, an aggregate amount of up to $
| 7. | Stock Warrants |
The Company’s outstanding warrants as of June 30, 2025 are summarized as follows, and all were exercisable at that date.
| Number of Shares | Exercise Price | Remaining Contractual Life (years) | ||||||||||
| Outstanding warrants expiring May 7, 2026 | $ | |||||||||||
| Outstanding warrants expiring September 11, 2026 | $ | |||||||||||
| Outstanding warrants at June 30, 2025 | ||||||||||||
December 2020 Warrants
The warrants issued pursuant to a securities purchase agreement, dated as of December 24, 2020, that the Company entered into with certain institutional and accredited investors and pursuant to which, among other things, the Company sold and issued, and the investors purchased, shares of the Company’s common stock and related warrants to purchase additional shares of the Company’s common stock in a series of two closings, contain a call provision whereby the Company, after the 13-month anniversary of the issuance date, and if the volume weighted average price of the common stock for such date exceeds four times the exercise price of the warrants for 20 consecutive trading days, may call the warrants that have not previously been exercised, and the warrant holders have ten trading days within which to exercise before the warrants may be cancelled. From among these warrants, warrants for
September 2024 Warrants
On September 12, 2024, the Company entered into securities purchase agreements with four private investors with respect to the private placement of an aggregate of
| 8. | Stock Options and Restricted Shares |
The outstanding options at June 30, 2025 consisted of the following:
| Weighted | ||||||||||||
| Average | ||||||||||||
| Remaining | ||||||||||||
| Number of | Exercise | Contractual Life | ||||||||||
| Shares | Price | (years) | ||||||||||
| Outstanding at December 31, 2024 | ||||||||||||
| Options Granted at $2.50 Exercise Price | $ | |||||||||||
| Options Expired at $26.50 Exercise Price | ( | ) | $ | |||||||||
| Options Expired at $21.10 Exercise Price | ( | ) | $ | |||||||||
| Options Expired at $24.40 Exercise Price | ( | ) | $ | |||||||||
| Options forfeited at $26.50 Exercise Price | ( | ) | $ | |||||||||
| Options Granted at $2.10 Exercise Price | $ | |||||||||||
| Outstanding at June 30, 2025 | ||||||||||||
| Outstanding Options at $20.00 Exercise Price | $ | |||||||||||
| Outstanding Options at $24.00 Exercise Price | $ | |||||||||||
| Outstanding Options at $90.00 Exercise Price | $ | |||||||||||
| Outstanding Options at $262.00Exercise Price | $ | |||||||||||
| Outstanding Options at $21.00 Exercise Price | $ | |||||||||||
| Outstanding Options at $21.10 Exercise Price | $ | |||||||||||
| Outstanding Options at $26.60 Exercise Price | $ | |||||||||||
| Outstanding Options at $15.00 Exercise Price | $ | |||||||||||
| Outstanding Options at $27.50 Exercise Price | $ | |||||||||||
| Outstanding Option at $17.60 Exercise Price | $ | |||||||||||
| Outstanding Options at $14.90 Exercise Price | $ | |||||||||||
| Outstanding Options at $22.00 Exercise Price | $ | |||||||||||
| Outstanding Options at $2.50 Exercise Price | $ | |||||||||||
| Options Granted at $2.10 Exercise Price | $ | |||||||||||
| Outstanding at June 30, 2025 | ||||||||||||
At June 30, 2025
On March 10, 2025, the Compensation Committee granted the non-employee directors and certain executives and consultants options to purchase
On May 21, 2025, the Compensation Committee (the "Compensation Committee") of the Company's Board of Directors (the "Board") granted a consultant options to purchase
As of June 30, 2025, the outstanding stock options had intrinsic value of $
Performance Options
On February 28, 2024, the Company issued options to an external party to purchase
| 9. | Related Party Transactions |
The Company has entered into lease agreements with SRI Professional Services, Incorporated (“SRI”), pursuant to which the Company leases equipment used in connection with the operation of its business (the “SRI Equipment Leases”). Phillip W. Oldridge, the Company’s Chief Executive Officer and Chairman of the Board, serves as an executive officer and a member of the board of directors of SRI. Two of the SRI Equipment Leases provide for the leasing of two vehicles that commenced on January 1, 2020 and the combined rent under such leases is $
The Company has entered into a commercial lease agreement (the “ABCI Office Lease”) with Alpha Bravo Charlie, Inc. (“ABCI”) that commenced on April 1, 2020, for the lease of office space in Porterville, California. The monthly rent for this facility is approximately $
The Company incurred $
The Company also expensed $
All revenue earned for the three and six months ended June 30, 2025 by the Company's medical supplies segment was from Maddox Defense, Inc., a company owned by Jason Maddox, President and Interim Chief Financial Officer of the Company.
The Company also maintains a procurement contract with EVTV Canada, a related party whereby one of its officers holds a significant number of shares in the Company.
| 10. | Commitments |
See Note 13 - Leases for further information.
| 11. | Contingencies |
Except as set forth below, we know of no material, existing or pending, legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder of more than 5% of our common stock, or any associate of any of the foregoing persons, is an adverse party or has a material interest adverse to our interest.
GreenPower Litigation
On December 17, 2019, GreenPower Motor Company Inc., a public company incorporated under the laws of British Columbia (“GreenPower”), of which Phillip W. Oldridge, the Company’s Chief Executive Officer and Chairman of the Board, previously served as a senior officer and a member of its board of directors, filed a notice of civil claim, captioned GreenPower Motor Company Inc. v. Phillip Oldridge et al., Action No. S-1914285, in the Supreme Court of British Columbia, against Phillip Oldridge, his trust, Envirotech Drive Systems, Inc. and certain other companies affiliated therewith. On February 2, 2020, the Company and the other companies affiliated therewith named in the notice of civil claim filed a response to the civil claim in which they denied certain of the allegations. Fact discovery, through document disclosure and examinations for discoveries, in this matter remains ongoing. The Company believes it has meritorious defenses against GreenPower's claims and intends to vigorously defend itself against those claims.
On or about July 18, 2021, GreenPower and GP GreenPower Industries Inc. (collectively “the GreenPower entities”), filed a counterclaim against David Oldridge, Phillip Oldridge, the Company and other companies in Supreme Court of British Columbia Action No. S207532. The pleadings in this lawsuit have not closed and the Company intends to vigorously defend itself against the counterclaim.
On February 8, 2022, GreenPower Motor Company, Inc., a Delaware corporation, and GreenPower Motor Company Inc., a Canadian corporation, filed a complaint captioned GreenPower Motor Company, Inc. v. Phillip Oldridge, et al., Case No. 5:22-cv-00252 in the United States District Court for the Central District of California. The complaint’s allegations are centered around the same assertions in the pending Canadian litigation.
On May 10, 2022, the Company, together with other defendants, filed a Motion to Dismiss and/or Stay the lawsuit in the United States District Court for the Central District of California pending the outcome of the Canadian litigation. The Court issued stay of this case pending resolution of parallel litigation in Canada between similar parties. GreenPower and defendants have agreed that the U.S. GreenPower case will not proceed while Canadian litigation is pending. The Company believes that it has meritorious defenses against the Greenpower entities' claims and intends to vigorously defend itself against such claims.
| 12. | Leases |
Operating leases
The Company has active operating lease arrangements for office space and warehouse facilities. The Company is typically required to make fixed minimum rent payments relating to its right to use the underlying leased assets. Although these leases have terms that are either month-to-month or terms that are one year or less (with renewal options), the Company concluded that the term renewal options are reasonably certain to be exercised, and the Company classified such leases as operating leases in accordance with the provisions of ASC 842.
On April 1, 2025, the Company entered into a three-year sub-lease arrangement with Maddox Defense (with renewal options), an entity of which Jason Maddox, the President and Interim Chief Financial Officer of the Company, is the sole stockholder, to lease a facility in Houston, Texas for its medical supplies operations. This lease is treated as an operating lease in accordance with the provisions of ASC 842. Therefore, the Company recognized operating lease liabilities with corresponding ROU assets based on the present value of the minimum rental payments of such leases.
On March 28, 2023, the Company entered into the Berthaphil Sublease with Berthaphil to sublease approximately
On July 1, 2024, the Company entered into a month-to-month lease contract to lease a residence in Osceola, Arkansas for the purpose of housing certain of the Company's employees. The monthly lease cost is $
On August 26, 2024, the Company entered into a one-year lease contract to lease a location in Manalapan, New Jersey with the purpose of servicing the Company's New Jersey customers. The monthly lease cost is $
The Company's lease agreements do not provide an implicit borrowing rate. Therefore, the Company used a benchmark approach to derive an appropriate incremental borrowing rate. The Company benchmarked itself against other companies of similar credit ratings and comparable credit quality and derived an incremental borrowing rate to discount each of its lease liabilities based on the remaining lease terms.
Quantitative information regarding the Company’s leases is as follows:
| Three Months Ended | Six Months Ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Lease expenses | ||||||||||||||||
| Operating lease expenses | $ | $ | $ | $ | ||||||||||||
| Short-term lease expenses | ||||||||||||||||
| Total lease cost | $ | $ | $ | $ | ||||||||||||
| Other information | ||||||||||||||||
| Cash paid for the amounts included in the measurement of lease liabilities for operating leases: | ||||||||||||||||
| Operating cash flows | $ | $ | $ | $ | ||||||||||||
| Weighted-average remaining lease term (in years): | ||||||||||||||||
| Operating leases | ||||||||||||||||
| Weighted-average discount rate: | ||||||||||||||||
| Operating leases | % | % | % | % | ||||||||||||
Future minimum payments under operating leases are as follows:
| Remainder of 2025 | $ | |||
| 2026 | $ | |||
| 2027 | $ | |||
| 2028 | $ | |||
| Total payments | $ |
| 13. | Segment Reporting |
The Chief Operating Decision Maker is the Chief Executive Officer, who reviews the segment operating results in order to allocate resources and assess performance.
The Company has identified three segments:
(1) Electric vehicles,
(2) Medical supplies and
(3) Drones
The electric vehicle segment consists of sales of commercial electric vehicles to customers. A significant portion of such sales are through state subsidized or funded programs. The medical supplies segment consists solely of sales to Maddox Defense, a related party based on an agreement to supply refurbished medical gowns on a cost-plus pricing arrangement. Through the Company's drone operations, it is also diversifying its portfolio of assets by engaging in the future production and supply of drones that will be used in the agricultural environment. Currently, activity within the Drones segment is limited to start up expenses and research and development activities.
The table below summarizes the operating results of the Company's segments for the three and six months ended June 30, 2025:
| Electric vehicles | Medical Supplies | Drones | Total | |||||||||||||
| Sales, net | $ | ( | ) | $ | $ | $ | ||||||||||
| Operating loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Interest income (expense), net | ||||||||||||||||
| Unrealized loss on financial instruments at fair value | ( | ) | ||||||||||||||
| Realized loss on conversion of convertible notes | ( | ) | ||||||||||||||
| Other expense | ||||||||||||||||
| Income tax expense | ||||||||||||||||
| Net loss | $ | ( | ) | |||||||||||||
| Six months ended June 30th , 2025 | ||||||||||||||||
| Electric vehicles | Medical Supplies | Drones | Total | |||||||||||||
| Sales, net | $ | $ | $ | $ | ||||||||||||
| Operating loss | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
| Interest income (expense), net | ||||||||||||||||
| Unrealized loss on financial instruments at fair value | ( | ) | ||||||||||||||
| Realized loss on conversion of convertible notes | ( | ) | ||||||||||||||
| Other expense | ( | ) | ||||||||||||||
| Income tax expense | ||||||||||||||||
| Net loss | $ | ( | ) | |||||||||||||
| 14. | Subsequent Events |
The Company evaluates subsequent events that have occurred after the balance sheet date but before the consolidated financial statements are issued. There are two types of subsequent events: (1) recognized, or those that provide additional evidence with respect to conditions that existed at the date of the balance sheet, including the estimates inherent in the process of preparing financial statements, and (2) non-recognized, or those that provide evidence with respect to conditions that did not exist at the date of the balance sheet but arose subsequent to that date.
Reverse 1-for-10 stock split
On August 6, 2025 (the “Split Effective Time”), the Company effected a reverse stock split of its Common Stock at a ratio of 1-for-
Appointment of Jason Maddox as a Class II Director
On August 5, 2025, the board of directors (the “Board”) of Envirotech Vehicles, Inc., a Delaware corporation (the “Company”), approved the appointment of Jason Maddox as a Class II director of the Company effective as of August 6, 2025, to serve until the 2025 Annual Meeting of Stockholders of the Company. Mr. Maddox has not been appointed to any committees of the Board.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion of our financial condition and the results of operations should be read in conjunction with the unaudited consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q (“Quarterly Report”) and the audited financial statements and notes thereto included in our Annual Report on Form 10-K filed with the SEC on April 15, 2025. This discussion contains forward-looking statements that are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. These risks, uncertainties, and other factors include, among others, those identified under the “Special Note Regarding Forward-Looking Statements” above in this Quarterly Report.
Overview
We are a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. We serve commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles. Our vehicles address the challenges of traditional fuel price instability and local, state and federal regulatory compliance. Beginning in January 2025, the Company operates under three segments: electric vehicles, medical supplies and drones.
On March 6, 2025, we received a letter (the “Notice”) from the Nasdaq Listing Qualifications Department, notifying us that, based upon the closing bid price of our common stock for the 30 consecutive business days from January 21, 2025 to March 5, 2025, we no longer meet the requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq has provided us with 180 calendar days, or until September 2, 2025 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. The Notice has no immediate effect on the listing of our common stock, which will continue to trade on the Nasdaq Capital Market under the symbol “EVTV”, subject to our compliance with the other continued listing requirements of the Nasdaq Capital Market.
On August 6, 2025, we filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the shares of the Company’s common stock (the “Reverse Stock Split”). The Company’s common stock began trading on a post-split basis on the Nasdaq Capital Market as of the open of trading on August 8, 2025. Upon the effectiveness of the Reverse Stock Split, every 10 issued and outstanding shares of the Company’s common stock were automatically combined into one share of common stock, without any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split. Instead, any fractional shares of Common Stock that would have otherwise resulted from the Reverse Stock Split were rounded up to the nearest whole share. Proportional adjustments were made to the number of shares of the Company’s common stock issuable upon exercise of the Company's outstanding stock options and warrants, as well as the applicable exercise prices, and to the number of shares issuable under the Company’s 2017 Equity Incentive Plan. The Reverse Stock Split did not affect the number of authorized shares of the Company’s common stock. All references made to share or per share amounts in the accompanying unaudited interim condensed consolidated financial statements and applicable disclosures have been retroactively adjusted for all periods presented to reflect the applicable effects of the Reverse Stock Split. Under Nasdaq Listing Rules, to regain compliance, the closing bid price of the Company’s common stock must be at least $1 per share for a minimum of ten consecutive business days to regain compliance with the Minimum Bid Price Requirement.
There can be no assurance that we will be able to regain compliance with the Minimum Bid Price Requirement or that we will be able to remain in compliance with the applicable Nasdaq listing requirements on an ongoing basis.
Factors Affecting Our Performance
We believe that the growth and future success of our business depend on various opportunities, challenges and other factors, including the following:
Availability of government subsidies, rebates and economic incentives. We believe that the availability of government subsidies, rebates, and economic incentives is currently a critical factor considered by our customers when purchasing our zero-emission systems or converting their existing vehicles to zero-emission-electric or hybrids, and that our growth depends in large part on the availability and amounts of these subsidies and economic incentives. As an alternative to being dependent on such funding, however, we are exploring the possibility of leasing our vehicles to our customers as well.
New customers. We are competing with other companies and technologies to help fleet managers and their districts/companies more efficiently and cost-effectively manage their fleet operations. Once these fleet managers have decided they want to buy from us, we still face challenges with helping them to obtain financing options to reduce the cost barriers to purchasing. We may also encounter customers with inadequate electrical services at their facilities that may delay their ability to purchase from us.
Dependence on external sources of financing of our operations. We have historically depended on external sources of capital to finance our operations. Accordingly, our future performance will depend in part upon our ability to achieve independence from external sources for the financing of our operations.
Investment in growth. We plan to continue to invest for long-term growth. We anticipate that our operating expenses will increase in the foreseeable future as we invest in research and development to enhance our zero-emission electric vehicles and systems; design, develop and manufacture our commercial fleet vehicles and their components; increase our sales and marketing to acquire new customers; and increase our general and administrative functions to support our growing operations. We believe that these investments will contribute to our long-term growth, although they will adversely affect our results of operations in the near term. In addition, the timing of these investments can result in fluctuations in our annual and quarterly operating results.
Zero-emission electric vehicle experience. Our dealer and service network is not currently completely established, although we do have certain agreements in place. One issue they may have, and we may encounter, is finding appropriately trained technicians with zero-emission electric fleet vehicle experience. Our performance will depend on having a robust dealer and service network, which will require appropriately trained technicians to be successful. Because vehicles that utilize our technology are based on a different technology platform than traditional internal combustion engines, individuals with sufficient training in zero-emission electric vehicles may not be available to hire, and we may need to expend significant time and expense training the employees we do hire. If we are not able to attract, assimilate, train or retain additional highly qualified personnel in the future, or do so cost-effectively, our performance would be significantly and adversely affected.
Market growth. We believe the market for all-electric solutions for alternative fuel technology, specifically all-electric vehicles, will continue to grow as more purchases of new zero-emission vehicles and as more conversions of existing fleet vehicles to zero-emission vehicles are made. However, unless the costs to produce such vehicles decrease dramatically, purchasers of our products will continue to depend in large part on financing subsidies from government agencies. We cannot be assured of the continued availability, the amounts of such assistance to our customers, or our ability to access such funds.
Sales revenue growth from additional products. We seek to add to our product offerings additional zero-emission vehicles of all sizes to be marketed, sold, warrantied and serviced through our developing distribution and service network, as well as add other ancillary products discussed elsewhere in this Quarterly Report.
Third-party contractors, suppliers and manufacturers. We rely upon third parties to supply us with raw materials, parts, components and services in adequate quantity in a timely manner and at reasonable prices, quality levels, and volumes acceptable to us. We also are solely reliant on one vendor which is a related party to provide all vehicles as there is currently no manufacturing in the United States.
Components of Results of Operations
Sales
Sales are recognized from the sales of new, purpose-built zero-emission electric vehicles and from providing vehicle maintenance and safety inspection services. Revenue is recognized at the point in time when control transfers to the customer, which in this arrangement, occurs when the gowns are delivered. Sales are recognized in accordance with ASC 606, as discussed in Note 2 to our unaudited consolidated financial statements included in this Quarterly Report.
Cost of Sales
Cost of sales includes those costs related to the development, manufacture, and distribution of our electric vehicles. Specifically, we include in cost of sales for our electric vehicles segment each of the following: material costs (including commodity costs); freight costs; labor and other costs related to the development and manufacture of our electric vehicles; and other associated costs. Cost of sales also includes costs related to the valuation of inventory due to impairment, obsolescence, or shrinkage. Cost of sales included in our medical supplies activities include direct labor and accessories such as tape, glues, etc. The main materials of our medical supplies segment are supplied by the customer.
General and Administrative Expenses
Selling, general and administrative expenses include all corporate and administrative functions that support our Company, including personnel-related expense and stock-based compensation costs; costs related to investor relations activities; including product recall and customer satisfaction program costs; consulting costs; marketing-related expenses; and other expenses that cannot be included in cost of sales.
Consulting and Research and Development Costs
These expenses are related to our consulting and research and development activity.
Other (Expense)Income, Net
Other (expense)/income include non-operating income and expenses, including interest income and expense, realized gain/(loss) on conversion of convertible notes and unrealized gain (loss) of financial instruments at fair value.
Provision for Income Taxes
We account for income taxes in accordance with ASC 740 which requires the recognition of deferred income tax assets and liabilities for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs. A valuation allowance is provided for certain deferred tax assets if it is more likely than not that we will not realize tax assets through future operations. Because we have incurred only losses to this point, no provision for income taxes has been made in 2024.
Results of Operations
The following discussion compares our results of operations for the three and six months ended June 30, 2025 to the corresponding periods ended June 30, 2024:
Sales
Sales for the three months ended June 30, 2025 and 2024 were $1,047,029 and $812,770, respectively. Sales for the three months ended June 30, 2025 of our electric vehicle segment were ($25,237) as certain credit memos were issued for operational purposes. Sales of our medical supplies segment consisted of delivery of medical supplies totaling $1,072,266 to a related party. Sales for the three months ended June 30, 2024 consisted primarily of five logistics cargo vans, one cab and chassis truck, one electric sweeper and one passenger van. The sales decrease in our electric vehicle segment was primarily due to less favorable market conditions.
Sales for the six months ended June 30, 2025 and 2024 were $1,637,595 and $1,623,260, respectively. Sales for the six months ended June 30, 2025 of our electric vehicle segment were $348,063 and consisted primarily of two logistics cargo vans and two cab and chassis trucks. Sales of our medical supplies segment consisted of delivery of medical supplies totaling $1,289,532 to a related party. Sales for our medical supplies segment is based on a cost-plus pricing structure. The sales decrease in our electric vehicle segment was primarily due to less favorable market conditions.
Cost of Sales
Cost of sales for the three months ended June 30, 2025 and 2024 were $2,504,746 and $608,947, respectively. Cost of sales of our electric vehicles segment was $1,523,713 for the three months ended June 30, 2025. Cost of sales of our medical supplies segment was $981,033 for the three months ended June 30, 2025. Cost of sales for our electric vehicles segment was related to the sales of the trucks and van and additional inventory write-downs while cost of sales for our medical supplies segment was based on a cost-plus pricing structure to a related party. Cost of sales for the three months ended June 30, 2024 consisted of the costs related to the sale of the electric vehicles sold as described above.
Cost of sales for the six months ended June 30, 2025 and 2024 were $2,975,921 and $1,111,218, respectively. Cost of sales of our electric vehicles segment was $1,788,075 for the six months ended June 30, 2025. Cost of sales of our medical supplies segment was $1,187,845 for the six months ended June 30, 2025. Cost of sales for our electric vehicles segment was related to the sales of the trucks and van and additional inventory write-downs of $1,172,302 while cost of sales for our medical supplies segment was based on a cost-plus pricing structure to a related party. Cost of sales for the six months ended June 30, 2024 consisted of the costs related to the sale of the electric vehicles sold as described above.
General and Administrative ("G&A") Expenses
G&A expenses were $2,751,788 and $1,466,748 for the three months ended June 30, 2025 and 2024, respectively. G&A expenses increased primarily due to higher provision for doubtful receivables, higher legal and accounting costs due to additional resources required for compliance and other matters, higher commissions as investment banking fees for the convertible notes, higher rents due to the Houston facility, additional rentals for housing and equipment and higher amortization expense from the Maddox Acquisition.
G&A expenses were $6,354,896 and $4,660,999 for the six months ended June 30, 2025 and 2024, respectively. G&A expenses increased primarily due to higher provision for doubtful receivables, higher legal and accounting costs due to additional resources required for compliance and other matters, higher payroll and contract labor for various operational projects at the Arkansas and Houston facilities, higher commissions as investment banking fees for the convertible notes, higher rents due to the Houston facility, additional rentals for housing and equipment and higher amortization expense from the Maddox Acquisition, partially offset by lower stock compensation costs due to favorable changes in the inputs to the valuation model.
Consulting Expenses
Consulting expenses were $46,511 for the six months ended June 30, 2025. These costs were incurred primarily for certain consulting services related to our medical supplies segment.
Research and Development ("R&D") Expenses
R&D expenses were $590,121 and $61,616 for the three months ended June 30, 2025 and 2024, respectively, as the level of activity increased. R&D expenses were $688,519 and $131,880 for the six months ended June 30, 2025 and 2024, respectively, primarily due to costs incurred in our drone segment to build certain prototypes.
Goodwill Impairment Charge
Due to our declining stock price, we conducted an impairment test related to our goodwill. As a result of this test, we recorded an impairment charge of $10,103,048 related to our goodwill for the three and six months ended June 30, 2025. No impairment charges were recorded for the three and six months ended June 30, 2024.
Unrealized loss on financial instruments at fair value
We recorded a non-cash unrealized loss of $290,144 for the three months ended June 30, 2025 and an unrealized gain of $570,519 for the three months ended June 30, 2024, on our financial instruments that we elected to measure at fair value. We recorded a non-cash unrealized loss of $573,937 and $999,408 for the six months ended June 30, 2025 and 2024, respectively, on our financial instruments that we elected to measure at fair value. These valuations are directly impacted by the changes in our stock price which declined since the instruments were issued.
Realized loss on conversion of convertible notes
We recognized a loss of $76,764 due to the conversion of the Promissory Notes and Additional Promissory Notes into the shares of the Company's common stock for the three and six months ended June 30, 2025.
Cash Flows
The following table summarizes our cash flows from operating, investing, and financing activities for the six months ended June 30, 2025 and 2024:
| Six months ended June 30, |
||||||||
| 2025 |
2024 |
|||||||
| Cash flows used in operating activities |
$ | (5,385,357 | ) | $ | (1,700,563 | ) | ||
| Cash flows used in investing activities |
(176,828 | ) | (135,288 | ) | ||||
| Cash flows provided by financing activities |
4,563,245 | 1,816,196 | ||||||
| Net change in cash, restricted cash and cash equivalents |
$ | (998,940 | ) | $ | (19,655 | ) | ||
Operating Activities
Net cash used in operating activities for the six months ended June 30, 2025 was $5,385,357, primarily due to a net loss of $19,183,118, partially offset by changes in operating assets and liabilities, net of $1,897,702 and non-cash operating changes of $11,900,059. The changes in operating assets and liabilities, net was due a decrease in accounts receivable of $576,374, a decrease in inventory of $1,560,698, a decrease in prepaid expenses and other current assets of $779,123, an increase in accounts payable of $694,769, an increase in deferred revenue of $2,284,415 as a result of fundings from the EPA grants and an increase of $508,381 in other liabilities primarily from the capitalization of the Houston lease, partially offset by an increase in related party receivable of $1,161,947 from our medical supplies segment, an increase in inventory deposits of $2,743,291, an increase in non-current assets of $568,154 primarily from the capitalization of the Houston lease as a ROU asset and a decrease in accrued liabilities of $32,666.
Net cash used in operating activities for the six months ended June 30, 2024 was $1,700,563, primarily due to a net loss of $5,287,455, partially offset by changes in operating assets and liabilities, net of $658,185 and non-cash operating charges of $2,928,519. The changes in operating assets and liabilities, net was due to a decrease in inventory deposits of $443,074, a decrease in prepaid expenses of $187,474, a decrease in inventory of $127,372, a decrease in other assets of $164,467, an increase in accounts payable of $195,786 and an increase in accrued liabilities of $438,089, partially offset by an increase in accounts receivable of $733,998 and a decrease in other liabilities of $164,079.
We expect cash used in operating activities to fluctuate significantly in future periods as a result of a number of factors, some of which are outside of our control, including, among others: the success we achieve in generating revenue; the success we have in helping our customers obtain financing and government incentives to subsidize their purchases of our products; our ability to efficiently develop our dealer and service network; the costs of batteries and other materials utilized to make our products; the extent to which we need to invest additional funds in research and development; the amount of expenses we incur to satisfy future warranty claims, and the ability to engage in supply medical supplies to the federal government on a long-term basis.
Investing Activities
Net cash used in investing activities during the six months ended June 30, 2025 was $176,828, primarily from the purchase of property and equipment that is used in our current operations.
Net cash used in investing activities during the six months ended June 30, 2024 was $135,288, primarily from the purchase of property and equipment that is used in our current operations.
Financing Activities
Net cash provided by financing activities during the six months ended June 30, 2025 was $4,563,245 primarily from the issuance of the Additional Promissory Notes for $4,750,500 in net proceeds, partially offset by loan repayments of $187,255.
Net cash provided by financing activities during the six months ended June 30, 2024 was $1,816,196, primarily due to proceeds from the issuance of our common stock of $949,248, proceeds from the issuance of a convertible note of $901,000, and proceeds from issuance of debt for $232,067, partially offset by the repayment of debt of $266,119. See Note 5 - Debt to our unaudited consolidated financial statements included in this Quarterly Report for additional information regarding these financing activities.
Liquidity and Capital Resources
As of June 30, 2025, we had cash and cash equivalents of $942,241 and negative working capital of approximately $120,030. We believe that our existing cash and cash equivalents and current business plan that provides us with third-party financing may be sufficient to fund our operations during the next twelve months and beyond. However, we may not successfully execute our business plan, and if we do not, we may need additional capital to continue our operations and support the increased working capital requirements associated with the fulfillment of purchase orders.
In February 2022, we announced the planned acquisition of a manufacturing facility located in Osceola, Arkansas. The facility, comprising approximately 580,000 square feet, currently serves as our operational base and is intended to become our primary manufacturing site. While we commenced investment in the facility and operations are active under a lease structure, the underlying property transaction remains subject to final closing. We continue to work collaboratively with the City of Osceola to finalize terms related to site development, easements, and purchase conditions.
On February 12, 2025, we announced the relocation of our corporate headquarters and the establishment of a new 86,000 square foot facility in Houston, Texas. This strategic move reinforces our commitment to expanding U.S. manufacturing, strengthening fleet services, and supporting the growing demand for commercial electric vehicles. We opened our new corporate headquarters and manufacturing facility in 2025. As a result of this relocation, we may incur additional capital expenditure and one-time relocation costs, which at the time of filing, are being estimated.
Amended and Restated Standby Equity Purchase Agreement
On October 31, 2024, the Company entered into the A&R SEPA with the Investor. The A&R SEPA amends and restates in its entirety the Original SEPA.
Pursuant to the A&R SEPA, except for so long as there is a balance outstanding under the Promissory Notes, we have the right, from time to time, until November 1, 2027, to require the Investor to purchase up to $25 million of shares of common stock, subject to certain limitations and conditions set forth in the A&R SEPA, by delivering written notice to the Investor. Pursuant to the A&R SEPA, the Investor advanced to the Company the Pre-Paid Advance in the amount of $3 million in exchange for the Company’s issuance to the Investor of the Promissory Notes in two tranches, resulting in net proceeds (net of discounts and fees) to the Company of $2,635,500. The Company received the first tranche of the Pre-Paid Advance in the principal amount of $2 million on October 31, 2024 in exchange for the Promissory Note dated October 31, 2024, and the second tranche of the Pre-Paid Advance in the principal amount of $1 million on December 17, 2024 in exchange for the Promissory Note dated December 17, 2024. The Promissory Notes will accrue interest on the outstanding principal balance at an annual rate equal to 0%, which will increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Promissory Notes) or a Registration Event (as defined in the Promissory Notes) for so long as such event remains uncured. The Promissory Notes will mature on November 13, 2025, which may be extended at the option of the Investor. The Promissory Notes are convertible at a conversion price equal to the lower of (i) $21.4800 per share or (ii) 93% of the lowest daily volume weighted average price of the Common Stock on Nasdaq as reported by Bloomberg L.P. during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which is $3.5800 per share, subject to adjustment from time to time in accordance with the terms contained in the Promissory Notes). Pursuant to the terms of the Original SEPA, the Company issued 6,410 shares of common stock to the Investor as a commitment fee.
During the first quarter of 2025, the obligation under the EVTV-2 Promissory Note in the principal amount of $1 million was fully satisfied through the conversion of the EVTV-2 Promissory Note into shares of our common stock. As a result of this conversion, 174,348 shares of our common stock were issued at a weighted average price of $5.70. During the same quarter, the obligation under the EVTV-1 Promissory Note in the principal amount of $2 million was partially satisfied through the conversion of the EVTV-1 Promissory Note into shares of our common stock. As a result of this conversion, 149,030 shares of our common stock were issued at a weighted average price of $4.10.
During the second quarter of 2025, the obligation under the EVTV-1 Promissory Note in the principal amount of $2 million was partially satisfied through the conversion of the EVTV-1 Promissory Notes into shares of our common stock. As a result of this conversion, 56,144 shares of our common stock were issued at a weighted average price of $2.50. The remaining principal balance of the EVTV-1 Promissory Notes on June 30, 2025 was $1,250,000. A realized gain of $4,145 was recognized as a result of this conversion for the three months ended June 30, 2025.
Supplemental Agreement to A&R SEPA
On February 24, 2025, we entered into the Supplemental Agreement with the Investor, which amends and supplements the A&R SEPA to: (i) provide for the advancement by the Investor to us, subject to the satisfaction of certain conditions as set forth in the Supplemental Agreement, of the Additional Pre-Paid Advance in the principal amount of $5 million to be evidenced by the Additional Promissory Notes in two tranches, (ii) amend the maturity date for the EVTV-1 Promissory Note to March 9, 2026, and (iii) amend the floor price for the Note EVTV-1 to $0.7130 per share.
The Additional Promissory Notes accrue interest on the outstanding principal balance at an annual rate equal to 5%, which will increase to an annual rate of 18% upon the occurrence of an Event of Default (as defined in the Additional Promissory Notes) or a Registration Event (as defined in the Additional Promissory Notes) for so long as such event remains uncured. The Additional Promissory Notes will mature on March 9, 2026, which may be extended at the option of the Investor. The Additional Promissory Notes are convertible at a conversion price equal to the lower of (i) $10.00 per share or (ii) 93% of the lowest daily VWAP during the five consecutive trading days immediately preceding the conversion date (but no lower than the “floor price” then in effect, which is $0.7130 per share, subject to adjustment from time to time in accordance with the terms contained in the Additional Promissory Notes).
The first tranche of the Additional Pre-Paid Advance was disbursed on February 25, 2025 in the principal amount of $3 million (with net proceeds to us of approximately $2.7 million after deducting discounts and fees) as evidenced by the EVTV-3 Additional Promissory Note issued to the Investor on February 24, 2025. The second tranche of the Additional Pre-Paid Advance in the principal amount of $2 million was advanced by the Investor to us upon approval by our stockholders, at a special meeting of stockholders held on May 1, 2025, of the issuance of shares of our common stock in excess of the Exchange Cap (as defined in the A&R SEPA).
The EVTV-4 Additional Promissory Note was disbursed to us on May 7, 2025. During the second quarter of 2025, the obligation under the EVTV-4 Promissory Note in the principal amount of $2 million was partially satisfied through the conversion of the EVTV-4 Promissory Note into shares of our common stock. As a result of this conversion, 853,275 shares of our common stock were issued at a weighted average price of $2.00. The remaining principal balance of the EVTV-4 Promissory Note on June 30, 2025, was $500,000. A realized loss of $80,909 was recognized as a result of this conversion for the three months ended June 30, 2025.
Capital Expenditures
We do not have any contractual obligations for ongoing capital expenditures at this time. We do, however, purchase equipment necessary to conduct our operations on an as needed basis and will continue increasing those expenditures as we transfer assembly and corporate functions to the Houston, Texas facility.
Contractual Obligations
Other than as disclosed in the unaudited consolidated financial statements in Item 1 of this Quarterly Report for the period ended June 30, 2025, we have no contractual obligations.
Critical Accounting Policies and Significant Judgments and Estimates
Our consolidated financial statements are prepared in accordance with GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.
We define our critical accounting policies as those accounting principles under GAAP that require us to make subjective estimates and judgments about matters that are uncertain and are likely to have a material impact on our financial condition and results of operations as well as the specific manner in which we apply those principles.
Smaller Reporting Company Status
We are a “smaller reporting company” as defined in Rule 12b-2 under the Exchange Act. We may continue to be a smaller reporting company if either (i) the market value of our shares held by non-affiliates is less than $250 million measured on the last business day of our most recently completed second fiscal quarter or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our shares held by non-affiliates is less than $700 million as of the last business day of our most recently completed second fiscal quarter. We may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not smaller reporting companies, including reduced disclosure about our executive compensation arrangements.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
We are exposed to market risks in the ordinary course of our business. We do not currently face material market risks such as interest rate fluctuation risk and foreign currency exchange risk. Our cash and cash equivalents include cash in readily available checking and money market accounts. These investments are not dependent on interest rate fluctuations that may cause the principal amount of these investments to fluctuate, and we do not expect such fluctuation will have a material impact on our financial conditions. If we issue additional debt in the future, we will be subject to interest rate risk. The majority of our expenses are denominated in the U.S. dollar.
We may face risks associated with the costs of raw materials, primarily batteries, as we go into production. To the extent these and other risks materialize, they could have a material effect on our operating results or financial condition. We currently anticipate that our international selling, marketing and administrative costs related to foreign sales, if any, will be largely denominated in United States dollars, which may create foreign currency exchange risk exposure.
ITEM 4. CONTROLS AND PROCEDURES
Limitations on Effectiveness of Controls and Procedures
In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide absolute assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) for the quarter ended June 30, 2025. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of such time due to the material weakness described below:
We have been unable to maintain appropriate segregation of duties. We have yet to fully resolve such deficiencies as of the date of this filing. We have engaged, and continue to seek additional, experienced accounting professionals with relevant expertise to provide additional accounting services to supplement our efforts and mitigate the negative effects of our limited accounting staff.
Changes in Internal Control over Financial Reporting
There was no change in the Company’s internal control over financial reporting during the most recent three-month period covered by this Quarterly Report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Except as described in Note 11 - Contingencies, there were no material developments during the quarter ended June 30, 2025 in the legal proceedings described in our Annual Report on Form 10-K for the year ended December 31, 2024
ITEM 1A. RISK FACTORS
There were no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2024.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
A list of exhibits is set forth at the end of this Quarterly Report on Form 10-Q for the information required by this item.
|
|
Incorporated by Reference |
|
|
|||||||||
| Exhibit Number |
Exhibit Description |
Form |
File No. |
Exhibit |
Filing Date |
Filed Herewith |
||||||
|
|
|
|
||||||||||
| 3.1 | Amended and Restated Certificate of Incorporation of the Company | 1-A POS | 024-10656 | 2.7 | 6/15/2017 | |||||||
| 3.2 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on June 8, 2018 | 8-K | 001-38078 | 3.1 | 6/11/2018 | |||||||
| 3.3 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on May 26, 2021 | 8-K | 001-38078 | 3.1 | 6/2/2021 | |||||||
| 3.4 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on June 24, 2022 | 8-K | 001-38078 | 3.1 | 6/28/2022 | |||||||
| 3.5 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Company filed with the Secretary of State of Delaware on August 6, 2025 | 8-K | 001-38078 | 3.1 | 8/6/2025 | |||||||
| 3.6 | Amended and Restated Bylaws of the Company | 1-A POS | 024-10656 | 2.8 | 6/15/2017 | |||||||
| 31.1 |
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer |
X |
||||||||||
| 31.2 |
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer |
X |
||||||||||
| 32.1# |
18 U.S.C. Section 1350 Certification of Chief Executive Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
X | ||||||||||
| 32.2# |
18 U.S.C. Section 1350 Certification of Chief Financial Officer, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
X | ||||||||||
| 101.INS |
Inline XBRL Instance Document* |
X |
||||||||||
| 101.SCH |
Inline XBRL Taxonomy Extension Schema Document* |
X |
||||||||||
| 101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document* |
X |
||||||||||
| 101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document* |
X |
||||||||||
| 101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document* |
X |
||||||||||
| 101.DEF |
Inline XBRL Taxonomy Extension Definitions Linkbase Document* |
X |
||||||||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). | |||||||||||
| # |
The information in Exhibits 32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference. |
| * |
In accordance with Rule 402 of Regulation S-T, this interactive data file is deemed not filed or part of this Quarterly Report for purposes of Sections 11 or 12 of the Securities Act or Section 18 of the Exchange Act and otherwise is not subject to liability under these sections. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Envirotech Vehicles, Inc. |
|||
| Date: August 18, 2025 |
By: |
/s/ Phillip W. Oldridge |
|
| Phillip W. Oldridge |
|||
| Chief Executive Officer |
|||
| (Principal Executive Officer) |
|||
| Date: August 18, 2025 | By: |
/s/ Jason Maddox |
|
| Jason Maddox |
|||
| President and Interim Chief Financial Officer |
|||
| (Principal Financial and Accounting Officer) |
|||
FAQ
What were Envirotech (EVTV) revenues for the quarter by segment?
Did Envirotech complete a reverse stock split and how did it affect shares?
How concentrated are Envirotech's receivables and customers?
What material allowances and inventory adjustments were recorded?
What financing arrangements does Envirotech have that could affect equity?
